ENANTA PHARMACEUTICALS INC's ticker is ENTA and the CUSIP is 29251M106. A total of 157 filers reported holding ENANTA PHARMACEUTICALS INC in Q1 2020. The put-call ratio across all filers is 1.27 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2021 | $1,227,000 | +3.1% | 24,885 | -12.0% | 0.01% | 0.0% |
| Q4 2020 | $1,190,000 | -49.2% | 28,277 | -44.8% | 0.01% | -57.1% |
| Q3 2020 | $2,344,000 | +0.3% | 51,201 | +9.9% | 0.01% | -6.7% |
| Q2 2020 | $2,338,000 | -39.4% | 46,570 | -37.9% | 0.02% | -46.4% |
| Q1 2020 | $3,859,000 | +104.3% | 75,034 | +145.3% | 0.03% | +154.5% |
| Q4 2019 | $1,889,000 | – | 30,583 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Krensavage Asset Management, LLC | 519,035 | $60,156,000 | 15.36% |
| Matarin Capital Management, LLC | 201,703 | $23,377,378,000 | 1.69% |
| ARMISTICE CAPITAL, LLC | 124,000 | $14,372,000 | 0.94% |
| Sapphire Star Partners LP | 7,803 | $904,000 | 0.93% |
| BOGLE INVESTMENT MANAGEMENT L P /DE/ | 98,631 | $11,431,000 | 0.83% |
| FARALLON CAPITAL MANAGEMENT LLC | 1,075,000 | $124,593,000 | 0.77% |
| Granahan Investment Management | 100,670 | $11,668,000 | 0.70% |
| Virtus ETF Advisers LLC | 6,577 | $762,000 | 0.67% |
| AlphaMark Advisors, LLC | 11,115 | $1,288,000 | 0.52% |
| Ativo Capital Management LLC | 15,029 | $1,742,000 | 0.48% |